Author

Hassan Taha

Observed names: Hassan S. Taha, Hassan S Taha, Hassan S. Taha

Observed institutions: Stormont Vail Health, Cotton University, Stanford University

OpenAlex ID: A5087931132

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

2022 · Thomas L. Holland, Adit A. Ginde, et al. · The Lancet Respiratory Medicine · 123

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4

Tixagevimab/Cilgavimab for Treatment of Hospitalised COVID-19 Patients: A Randomised, Double-Blind, Phase 3 Trial

2022 · Thomas L. Holland, Adit A. Ginde, et al. · SSRN Electronic Journal · 3

Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials

2025 · Kirk U. Knowlton, Lianne K. Siegel, et al. · PLoS Medicine · 2

Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials

2026 · Christian Møller Jensen, Ramtin Zargari Marandi, et al. · JAMIA Open

Passive Immunotherapy for Adults Hospitalized with COVID-19: An Individual Participant Data Meta-Analysis of Six Double-Blind, Randomized, Placebo-Controlled Trials

2025 · Kirk U. Knowlton, Lianne Siegel, et al. · SSRN Electronic Journal

Works count: 8

Citation count: 178

H-index: 4

I10-index: 3